✦ LIBER ✦

Immunologic heterogeneity of mammary tumor cells defined by monoclonal antibodies to tumor-associated antigens (TAAs)

✍ Scribed by Patricia Horan Hand; Marianna Nuti; David Colcher; Jeffrey Schlom

Publisher: Elsevier Science
Year: 1982
Tongue: English
Weight: 57 KB
Volume: 4
Category: Article
ISSN: 0192-0561
DOI: 10.1016/0192-0561(82)90069-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Characterization of human ovarian carcin

Characterization of human ovarian carcinoma-associated antigens defined by novel monoclonal antibodies with tumor-restricted specificity

✍ S. Miotti; S. Canevari; S. Ménard; D. Mezzanzanica; G. Porro; S. M. Pupa; M. Reg 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 French ⚖ 1019 KB

Three new monoclonal antibodies (MAbs) (MOv16, MOv18 chemical characterization of 3 MAbs obtained using this novel and MOv 19) were raised against human ovarian carcinoma. approach, 2 of which show tumor-restricted reactivities.To obtain more specific reagents than those produced so far, we adopted

Complement-dependent lysis of tumor cell

Complement-dependent lysis of tumor cells by a baboon IgM antibody to a tumor-associated antigen

✍ Kelly K. Hunt; Masahiko Shibata; Rishab K. Gupta; Donald L. Morton 📂 Article 📅 1992 🏛 Springer-Verlag 🌐 English ⚖ 873 KB

Localization of human breast tumors graf

Localization of human breast tumors grafted in nude mice with a monoclonal antibody directed against a defined cell surface antigen of human mammary epithelial cells

✍ Roberto L. Ceriani; Masao Sasaki; Douglas Orthendahl; Leon Kaufman 📂 Article 📅 1988 🏛 Springer US 🌐 English ⚖ 959 KB

L3P40-50—a new lung-tumor-associated 40-

L3P40-50—a new lung-tumor-associated 40- to 50-kDa antigen defined by a monoclonal antibody (L3)

✍ Fred-Thomas Brezicka; Sante Olling 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 French ⚖ 515 KB

A monoclonal antibody (MAb), designated L3, was raised against a human-lung-adenocarcinoma-derived cell line, A549. lmmunohistological studies showed reactivity of MAb L3 with 70 to 90% of lung tumors representing the 4 major histotypes. Strongest reactivity was seen with squamous-cell cancer and a

In vivo efficacy of monoclonal antibody

In vivo efficacy of monoclonal antibody — drug conjugates of three different subisotypes which bind the human tumor — associated antigen defined by the KS1/4 monoclonal antibody

✍ James J. Starling; Ronald S. Maciak; N. Ann Hinson; Cynthia L. Nichols; Stephen 📂 Article 📅 1989 🏛 Springer-Verlag 🌐 English ⚖ 925 KB

A panel of three hybridomas has been isolated each of which secretes a single species of monoclonal antibody (MoAb) directed against the KS1/4 tumor-associated antigen originally described by Varki et al. (Cancer Res 44: 681, 1984). These MoAbs were designated L1-(IgG2b), L2-(IgG1), and L4-(IgG2a)KS

Induction of antibodies to a tumor-assoc

Induction of antibodies to a tumor-associated antigen by immunization with a whole melanoma cell vaccine

✍ David M. Euhus; Rishab K. Gupta; Donald L. Morton 📂 Article 📅 1989 🏛 Springer-Verlag 🌐 English ⚖ 922 KB

Urinary-tumor-associated antigen (U-TAA) is a glycoprotein present in the urine of melanoma patients. Previous studies have addressed the role of U-TAA in immunoprognosis. The present investigation was undertaken to determine whether the administration of whole melanoma cell vaccine (MCV) could indu